Aβ-induced synaptic alterations require the E3 ubiquitin ligase Nedd4-1

Journal of Neuroscience

Volumn 36, Issue 5, 2016, Pages 1590-1595

  Rodrigues, Elizabeth M ^a   Scudder, Samantha L ^a   Goo, Marisa S ^a   Patrick, Gentry N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abeta; AMPA receptor; Endocytosis; Nedd4 1; Ubiquitin

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; LENTIVIRUS VECTOR; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE NEDD4; ESCRT PROTEIN; NEDD4 UBIQUITIN PROTEIN LIGASES; UBIQUITIN PROTEIN LIGASE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; BRAIN CELL CULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENDRITIC SPINE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPAL NEURONAL CULTURE; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RAT; SYNAPTIC POTENTIAL; UBIQUITINATION; VOLTAGE CLAMP TECHNIQUE; WESTERN BLOTTING; ANIMAL; CHO CELL LINE; CRICETULUS; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; HAMSTER; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SYNAPSE;

AMYLOID BETA-PEPTIDES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; HUMANS; MALE; RATS; RECEPTORS, AMPA; SYNAPSES; UBIQUITIN-PROTEIN LIGASES;

EID: 84957804771     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2964-15.2016     Document Type: Article

References (22)

1. Alfonso S, Kessels HW, Banos CC, Chan TR, Lin ET, Kumaravel G, Scannevin RH, Rhodes KJ, Huganir R, Guckian KM, Dunah AW, Malinow R (2014) Synapto-depressive effects of amyloid beta require PICK1. Eur J Neurosci 39:1225–1233.
2. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK (2005) Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20:187–198.
3. Carter TL, Rissman RA, Mishizen-Eberz AJ, Wolfe BB, Hamilton RL, Gandy S, Armstrong DM (2004) Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer’s disease patients according to Braak stage. Exp Neurol 187:299–309.
4. Chang EH, Savage MJ, Flood DG, Thomas JM, Levy RB, Mahadomrongkul V, Shirao T, Aoki C, Huerta PT (2006) AMPA receptor downscaling at the onset of Alzheimer’s disease pathology in double knockin mice. Proc Natl Acad Sci U S A 103:3410–3415.
5. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79–84.
6. Ehlers MD (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28:511–525.
7. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356.
8. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831–843.
9. Kwak YD, Wang B, Li JJ, Wang R, Deng Q, Diao S, Chen Y, Xu R, Masliah E, Xu H, Sung JJ, Liao FF (2012) Upregulation of the E3 ligase Nedd4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration. J Neurosci 32:10971–10981.
10. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155:853–862.
11. Lussier MP, Nasu-Nishimura Y, Roche KW (2011) Activity-dependent ubiquitination of theAMPAreceptor subunit GluA2. J Neurosci 31:3077–3081.
12. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46: 860–866.
13. Nixon RA, Yang DS (2011) Autophagy failure in Alzheimer’s disease, locating the primary defect. Neurobiol Dis 43:38–45.
14. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, Selkoe DJ (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270: 9564–9570.
15. Schwarz LA, Hall BJ, Patrick GN (2010) Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway. J Neurosci 30:16718–16729.
16. Scudder SL, Goo MS, Cartier AE, Molteni A, Schwarz LA, Wright R, Patrick GN (2014) Synaptic strength is bidirectionally controlled by opposing activity-dependent regulation of Nedd4-1 and USP8. J Neurosci 34: 16637–16649.
17. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298: 789–791.
18. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842.
19. Shepherd JD, Huganir RL (2007) The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 23:613–643.
20. Small DH (2012) Dysregulation of Ca2 homeostasis in Alzheimer’s disease: role in acetylcholinesterase production and AMPA receptor internalization. Neurodegener Dis 10:76–79.
21. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051–1058.
22. Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto S, Dziewczapolski G, Nakamura T, Cao G, Pratt AE, Kang YJ, Tu S, Molokanova E, McKercher SR, Hires SA, Sason H, Stouffer DG, Buczynski MW, Solomon JP, Michael S, et al. (2013) Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A 110:2518–2527.